A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells.
Year: 1999
Type: article
Source: PubMed
Authors: M Mutoh, F D Lung, Y Q Long, P P Roller, R S Sikorski, P M O'Connor
Institutions: National Institutes of Health, National Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1484870769
